Profile | GDS5420 / 211355_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 29.81 | 24 |
GSM1296119 | B_lesional_pre-dose | 154.16 | 47 |
GSM1296076 | C_lesional_pre-dose | 71.32 | 37 |
GSM1296092 | D_lesional_pre-dose | 63.21 | 37 |
GSM1296103 | E_lesional_pre-dose | 32.5 | 25 |
GSM1296078 | F_lesional_pre-dose | 86.21 | 40 |
GSM1296107 | G_lesional_pre-dose | 177.45 | 50 |
GSM1296109 | H_lesional_pre-dose | 94.45 | 39 |
GSM1296080 | I_lesional_pre-dose | 95.42 | 42 |
GSM1296090 | J_lesional_pre-dose | 69.87 | 37 |
GSM1296074 | K_lesional_pre-dose | 25.64 | 23 |
GSM1296111 | L_lesional_pre-dose | 105.09 | 40 |
GSM1296099 | M_lesional_pre-dose | 65.15 | 35 |
GSM1296086 | O_lesional_pre-dose | 52.48 | 33 |
GSM1296117 | P_lesional_pre-dose | 138.56 | 45 |
GSM1296113 | Q_lesional_pre-dose | 349.22 | 61 |
GSM1296096 | R_lesional_pre-dose | 49.97 | 32 |
GSM1296105 | S_lesional_pre-dose | 69.87 | 35 |
GSM1296098 | T_lesional_pre-dose | 90.56 | 39 |
GSM1296101 | U_lesional_pre-dose | 31.81 | 24 |
GSM1296121 | V_lesional_pre-dose | 78.58 | 36 |
GSM1296088 | W_lesional_pre-dose | 38.52 | 28 |
GSM1296082 | X_lesional_pre-dose | 96.87 | 43 |
GSM1296115 | Y_lesional_pre-dose | 173.37 | 49 |
GSM1296084 | Z_lesional_pre-dose | 40.34 | 27 |
GSM1296072 | B_lesional_day8 | 110.69 | 41 |
GSM1296069 | L_lesional_day8 | 84.66 | 35 |
GSM1296071 | P_lesional_day8 | 244.58 | 54 |
GSM1296070 | Y_lesional_day8 | 269.53 | 56 |
GSM1296073 | V_lesional_day8 | 77.71 | 37 |
GSM1296034 | A_lesional_day15 | 51.8 | 30 |
GSM1296041 | G_lesional_day15 | 109.41 | 41 |
GSM1296035 | R_lesional_day15 | 28.33 | 25 |
GSM1296038 | U_lesional_day15 | 30.42 | 24 |
GSM1296047 | B_lesional_day15 | 86.29 | 37 |
GSM1296039 | E_lesional_day15 | 42.85 | 28 |
GSM1296042 | H_lesional_day15 | 162.08 | 47 |
GSM1296043 | L_lesional_day15 | 77.04 | 34 |
GSM1296037 | M_lesional_day15 | 57.1 | 32 |
GSM1296046 | P_lesional_day15 | 256.62 | 55 |
GSM1296044 | Q_lesional_day15 | 386.02 | 62 |
GSM1296045 | Y_lesional_day15 | 276.1 | 56 |
GSM1296025 | C_lesional_day15 | 93.16 | 41 |
GSM1296033 | D_lesional_day15 | 88.76 | 40 |
GSM1296027 | I_lesional_day15 | 111.35 | 45 |
GSM1296032 | J_lesional_day15 | 136.26 | 46 |
GSM1296024 | K_lesional_day15 | 34.86 | 27 |
GSM1296031 | W_lesional_day15 | 102.16 | 41 |
GSM1296028 | X_lesional_day15 | 78.43 | 38 |
GSM1296029 | Z_lesional_day15 | 43.55 | 30 |
GSM1296026 | F_lesional_day15 | 66 | 35 |
GSM1296030 | O_lesional_day15 | 23.58 | 23 |
GSM1296040 | S_lesional_day15 | 17.33 | 15 |
GSM1296036 | T_lesional_day15 | 42.54 | 27 |
GSM1296048 | V_lesional_day15 | 80.6 | 37 |
GSM1296059 | A_lesional_day43 | 45.06 | 30 |
GSM1296066 | G_lesional_day43 | 181.82 | 50 |
GSM1296060 | R_lesional_day43 | 25.6 | 22 |
GSM1296063 | U_lesional_day43 | 85.78 | 38 |
GSM1296064 | E_lesional_day43 | 79.12 | 38 |
GSM1296067 | H_lesional_day43 | 139.29 | 44 |
GSM1296062 | M_lesional_day43 | 60.98 | 34 |
GSM1296068 | Q_lesional_day43 | 321.73 | 59 |
GSM1296050 | C_lesional_day43 | 172.97 | 50 |
GSM1296057 | D_lesional_day43 | 80.46 | 38 |
GSM1296052 | I_lesional_day43 | 139.43 | 48 |
GSM1296054 | J_lesional_day43 | 71.79 | 36 |
GSM1296049 | K_lesional_day43 | 75.82 | 37 |
GSM1296055 | W_lesional_day43 | 69.32 | 35 |
GSM1296053 | X_lesional_day43 | 78.75 | 38 |
GSM1296058 | Z_lesional_day43 | 55.38 | 34 |
GSM1296051 | F_lesional_day43 | 69.53 | 36 |
GSM1296056 | O_lesional_day43 | 23.52 | 22 |
GSM1296065 | S_lesional_day43 | 72.21 | 36 |
GSM1296061 | T_lesional_day43 | 87.01 | 39 |
GSM1296095 | A_non-lesional_pre-dose | 146.12 | 48 |
GSM1296120 | B_non-lesional_pre-dose | 137.63 | 45 |
GSM1296077 | C_non-lesional_pre-dose | 137.8 | 47 |
GSM1296093 | D_non-lesional_pre-dose | 65.45 | 34 |
GSM1296104 | E_non-lesional_pre-dose | 65.45 | 35 |
GSM1296079 | F_non-lesional_pre-dose | 119.88 | 45 |
GSM1296108 | G_non-lesional_pre-dose | 329.54 | 60 |
GSM1296110 | H_non-lesional_pre-dose | 308.42 | 58 |
GSM1296081 | I_non-lesional_pre-dose | 142.67 | 48 |
GSM1296091 | J_non-lesional_pre-dose | 95.18 | 42 |
GSM1296075 | K_non-lesional_pre-dose | 108.3 | 44 |
GSM1296112 | L_non-lesional_pre-dose | 199.21 | 50 |
GSM1296100 | M_non-lesional_pre-dose | 7.08 | 7 |
GSM1296087 | O_non-lesional_pre-dose | 54.19 | 34 |
GSM1296118 | P_non-lesional_pre-dose | 158.16 | 46 |
GSM1296114 | Q_non-lesional_pre-dose | 501.86 | 67 |
GSM1296097 | R_non-lesional_pre-dose | 41.31 | 29 |
GSM1296106 | S_non-lesional_pre-dose | 41.98 | 27 |
GSM1296102 | U_non-lesional_pre-dose | 43.22 | 28 |
GSM1296122 | V_non-lesional_pre-dose | 126.62 | 43 |
GSM1296089 | W_non-lesional_pre-dose | 132.7 | 45 |
GSM1296083 | X_non-lesional_pre-dose | 102.1 | 42 |
GSM1296116 | Y_non-lesional_pre-dose | 359.73 | 61 |
GSM1296085 | Z_non-lesional_pre-dose | 72.2 | 36 |